CRO Pricing: Benchmarks That Don’t Matter
Irrelevant benchmarks make for confused and lazy pricing decisions!

CRO Pricing: Benchmarks That Don’t Matter

Full-service CROs may offer services across 10 or more categories. Wouldn’t it be nice to know what the benchmarks are for what percentages of a full-service budget those categories should each represent, at least for a few key buckets like project management, clinical operations, and data management?

No. I rarely found these valuable when I was in-house, and find them less valuable over the past 3 years of consulting across a wide range of CROs of all sizes. In fact, they can be quite dangerous.

Project Management is the most common one I’m asked for. “We use 15%, what do others use?” My response is some form of “it doesn’t matter”.

Proportions like these completely depend on the mix of service categories involved, the specs and assumptions of each project, project complexity, each company’s staffing mix, among many other factors. Most outsourced clinical research projects are indeed complex- that’s why CROs exist!- and relying on high-level percentage benchmarks makes it too easy to take your focus away from getting every part of the budget right, scoped to the exact requirements of the project, resourced in a way to maximize a successful delivery.

Maybe 15% worked on the last project, but if the next project has fewer service categories, or is 100% in Europe, or has extremely complex biostatistics requirements, or involves numerous expensive technology offerings, or is in an ultra-rare indication, or any number of other factors, then that 15% doesn’t matter.

It doesn’t matter if 15% was your average over the past 12 months, or whether 3 of your main competitors like to use 12% or 20%- what matters is whether you priced the full scope of services properly for the new project. Relying on these high-level percentages for decision-making is dangerous, as it simply distracts from pricing the new project as accurately as possible.

So do any CRO pricing benchmarks matter? Of course!

If you’ve priced a key role at $250/hour while most competitors are at $180-$200 or $350-$400, that variance will affect your competitive positioning (especially if you’re significantly higher) and/or have you leaving significant margin on the table (if you’re significantly underpriced). Same situation if you’ve assumed a common key task takes 20 hours per unit to complete while competitors are 20%-30% lower or 50% higher.

These benchmarks matter and are useful because they help you price specific roles and services as competitively and profitably as possible, so that the sum of the parts- when built into a full budget- put you in a competitive and profitable position and help you anticipate how customers will evaluate different areas of your budget.


I specialize in pricing strategies for service and technology providers, with a focus on CROs. Contact me to discuss solutions for your organization.

Cathy Tropmann, RPh

Clinical Trial Consulting

9 个月

Totally agree Joel....

回复
Maria P. Ladd

Consultant l Site Support and Start-up l SOPs, Processes, Documentation, Tools l Issue Resolution

9 个月

Informative and accurate - but the curve ball is the practice of underpricing to win a bid and slowly buying it back via change orders. It's a common practice and strikes me as an eyes wide shut aporoach; everyone knows but usually feels pressured to do it or never win a bid.

Jen F.

Pharmacovigilance | Clinical Trials | Partnerships | Business Development

9 个月

Really great one!

Charlene Dark

Chief Operating Officer - Avania | Clinical Trials Executive | Transforming Healthcare through Leadership & Innovation

9 个月

Thank you for, once again, providing a pragmatic and logical view to this important topic.

Jodi Andrews

Founder and Co-CEO, ProTrials Research, Inc. / Board Member

9 个月

You are absolutely correct Joel. Thanks for the article.

要查看或添加评论,请登录

Joel White的更多文章

  • Locus of Control

    Locus of Control

    We can’t control when a client sets their RFP deadline, but we can request an extension, explain how the client would…

    35 条评论
  • Revenge Pricing

    Revenge Pricing

    “Revenge is an admission that we have been hurt. That cannot be a great mind which is disturbed by injury.

    15 条评论
  • Book to Bill Math

    Book to Bill Math

    For Q4 2024, IQVIA reported a 1.20 book to bill, Medpace reported 0.

    14 条评论
  • Tariffs, Strong Dollar, CROs, Offshoring

    Tariffs, Strong Dollar, CROs, Offshoring

    When I play out how US tariffs could affect CROs, I keep coming back to their impact on ??????????????? ??????????. The…

    8 条评论
  • Cutting Macros Down to Size

    Cutting Macros Down to Size

    Love ‘em or hate ‘em, Excel VBA macros are and will continue to be a necessary part of efficient Excel based pricing…

    1 条评论
  • Unit Definitions for Service Providers

    Unit Definitions for Service Providers

    Every service provider communicates its pricing to customers in some fashion. Some service providers (like my lawn guy)…

    20 条评论
  • (My) 2024 Year in Review

    (My) 2024 Year in Review

    I opened shop in June 2021, so 2024 marks my 3rd full calendar year in business as a full-time independent consultant…

    28 条评论
  • CNS Summit - "The State of CROs"

    CNS Summit - "The State of CROs"

    Last month I presented on "The State of CROs" at CNS Summit's 15th anniversary, via a Q&A format with AMIR KALALI, MD…

    15 条评论
  • The Change Order Czar

    The Change Order Czar

    I’m writing this on December 8th, 23 calendar days before the year is gone, with only 12-14 of those being “business…

    7 条评论
  • Video Training for Complex Pricing Tools

    Video Training for Complex Pricing Tools

    Service providers in complex industries (like clinical research) tend to require complex pricing tools. These pricing…

    4 条评论

社区洞察

其他会员也浏览了